Based on GWR models, higher household income was the only estimate in the model that showed a positive trend for higher off-label prescribing across the entire US (0.00008 [0.00002, 0.00016]) (Supplementary Table 2).
← all excerpts
Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor Agonists.
1
—
—